Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-06

Clinical Trial Update: Clevidipine in the Postoperative Treatment of Hypertension (ECLIPSE-NIC) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating clevidipine for postoperative hypertension (ECLIPSE-NIC) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLEVIPREX (clevidipine)

Snippet

Sponsor: The Medicines Company | Conditions: Hypertension | Phase 3 | Status: COMPLETED